Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Sleep Cycle AB ( (SE:SLEEP) ) is now available.
Sleep Cycle has announced a pilot collaboration with Ultrahuman, a global health and wellness company, to license its ‘Sleep SDK’ technology. This partnership aims to integrate Sleep Cycle’s technology into Ultrahuman’s ecosystem to enhance user health optimization. The collaboration is part of Sleep Cycle’s strategy to grow through partnerships and licensing, marking a significant step in expanding its reach and creating new revenue streams.
The most recent analyst rating on (SE:SLEEP) stock is a Hold with a SEK24.50 price target. To see the full list of analyst forecasts on Sleep Cycle AB stock, see the SE:SLEEP Stock Forecast page.
More about Sleep Cycle AB
Sleep Cycle is a company focused on making healthy sleep accessible through its app, which helps users identify sleep issues and gain insights into sleep patterns. The company uses patented sound technology and has analyzed over 3 billion sleep sessions, offering personalized guidance. Sleep Cycle is headquartered in Gothenburg, Sweden, and is listed on Nasdaq Stockholm under the ticker SLEEP. It also provides partnership opportunities for businesses to expand their offerings with sleep solutions and insights.
YTD Price Performance: -33.64%
Average Trading Volume: 39,971
Technical Sentiment Signal: Sell
Current Market Cap: SEK469.4M
Find detailed analytics on SLEEP stock on TipRanks’ Stock Analysis page.